ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.

Wei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.